Company:  VICAL INC (VICL)
Form Type:  10-Q
Filing Date:  8/8/2012 
CIK:  0000819050 
Address:  10390 PACIFIC CENTER COURT
.
 
City, State, Zip:  SAN DIEGO, California 92121-4340 
Telephone:  858-646-1100 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.17  
Change: 
-0.02 (-1.68%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$101.60M
Description of Business
We research and develop biopharmaceutical products based on our patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. We believe the following areas of research offer the greatest potential for near-term commercialization for us and our partners: � Vaccines for use in high-risk populations for infectious disease targets for which there are significant needs; and � Vaccines for general pediatric, adolescent and adult populations for infectious disease applications.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      ITEM 1. FINANCIAL STATEMENTS
        BALANCE SHEET
        CASH FLOW
        NOTES TO FINANCIAL STATEMENTS
          BALANCE SHEET
      ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 4. CONTROLS AND PROCEDURES
    PART II. OTHER INFORMATION
      ITEM 1A. RISK FACTORS
      ITEM 6. OTHER INFORMATION
      ITEM 6. EXHIBITS
    SIGNATURE
  EXHIBIT 10.1
  EXHIBIT 10.3
  EXHIBIT 10.4
  EXHIBIT 10.5
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
    CERTIFICATION PURSUANT TO
  EXHIBIT 32.2
    CERTIFICATION PURSUANT TO
BROKERAGE PARTNERS